As an inhibitor of PI3Kβ in the PI3K/Akt pathway, AZD6482 can exert an anti-tumor effect by inhibiting proliferation and inducing apoptosis in human GBN tumor cells (Xu et al., 2019). Here, AKT1 is linked to neoplasm.